Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum
Sign Up to like & getrecommendations! Published in 2019 at "Neurochemistry International"
DOI: 10.1016/j.neuint.2019.01.016
Abstract: ABSTRACT The psychostimulant methylphenidate (MPH) is the primary drug treatment for attention deficit hyperactivity disorder (ADHD) in children. MPH is well known to acutely block the dopamine (DAT) and noradrenaline (NET) transporters. Its effect on… read more here.
Keywords: parietal cortex; ventral striatum; mph; treatment ... See more keywords